These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11179479)

  • 1. Epitope-dependent differential immunoreactivities of anti-MUC1 monoclonal antibodies in human carcinomas.
    Baldus SE; Goergen D; Hanisch FG; Dienes HP
    Int J Oncol; 2001 Mar; 18(3):507-12. PubMed ID: 11179479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity clusters of MUC1-reactive mouse monoclonal antibodies.
    Hanisch FG
    Tumour Biol; 1998; 19 Suppl 1():111-7. PubMed ID: 9422095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
    Baldus SE; Zirbes TK; Glossmann J; Fromm S; Hanisch FG; Mönig SP; Schröder W; Schneider PM; Flucke U; Karsten U; Thiele J; Hölscher AH; Dienes HP
    Oncology; 2001; 61(2):147-55. PubMed ID: 11528254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
    Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
    Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues.
    Cao Y; Karsten U; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():88-99. PubMed ID: 9422093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse mucin 1 (MUC1) defined by monoclonal antibodies.
    Xing PX; Lees C; Lodding J; Prenzoska J; Poulos G; Sandrin M; Gendler S; McKenzie IF
    Int J Cancer; 1998 Jun; 76(6):875-83. PubMed ID: 9626356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
    Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
    Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactivity of Thomsen-Friedenreich (TF) antigen in human neoplasms: the importance of carrier-specific glycotope expression on MUC1.
    Baldus SE; Hanisch FG; Monaca E; Karsten UR; Zirbes TK; Thiele J; Dienes HP
    Histol Histopathol; 1999 Oct; 14(4):1153-8. PubMed ID: 10506931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
    Hanisch FG; Stadie T; Bosslet K
    Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope characterization of MUC1 antibodies.
    Blockzjil A; Nilsson K; Nilsson O
    Tumour Biol; 1998; 19 Suppl 1():46-56. PubMed ID: 9422088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
    Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
    Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
    Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast epitope mapping for the anti-MUC1 monoclonal antibody by combining a one-bead-one-glycopeptide library and a microarray platform.
    Garcia-Martin F; Matsushita T; Hinou H; Nishimura S
    Chemistry; 2014 Nov; 20(48):15891-902. PubMed ID: 25303614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
    Dai J; Allard WJ; Davis G; Yeung KK
    Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of antibody binding to mucin glycopeptides in lung cancer.
    Qu J; Yu H; Li F; Zhang C; Trad A; Brooks C; Zhang B; Gong T; Guo Z; Li Y; Ragupathi G; Lou Y; Hwu P; Huang W; Zhou D
    Int J Oncol; 2016 Feb; 48(2):587-94. PubMed ID: 26692014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
    Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
    Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.
    Matsushita T; Takada W; Igarashi K; Naruchi K; Miyoshi R; Garcia-Martin F; Amano M; Hinou H; Nishimura S
    Biochim Biophys Acta; 2014 Mar; 1840(3):1105-16. PubMed ID: 24246952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.
    Karsten U; Diotel C; Klich G; Paulsen H; Goletz S; Müller S; Hanisch FG
    Cancer Res; 1998 Jun; 58(12):2541-9. PubMed ID: 9635576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.